Abstract
The practice of oncology is under going significant advances, and better understanding of molecular biology along with new diagnostic techniques and chemotherapeutic agents have improved the management of many cancer patients. Nuclear imaging can provide important information regarding tumor diagnosis, staging, detection of relapse or residual tumor, response to therapy, and prognosis for a variety of tumors. Currently available images have high diagnostic sensitivity, but low specificity. The use of the tomographic concept in nuclear medicine is as old as the art of radionuclide imaging itself. Single photon and positron emission tomography aim to reconstruct a three-dimensional image displaying the distribution of a radiotracer administered to a patient.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Silberstein EB, Fernando-Ulloa M, Hall J. Are oral cathartics of value in optimizing the gallium scan? J Nucl Med 1981;22:424–427.
Engelstad B, Luk SS, Hattner RS. Altered Ga-67 citrate distribution in patients with multiple red blood cell transfusions. AJR 1982;139:755–759.
McLaughlin AF, Magee MA, Greenough R, et al. Current role of gallium scanning in the management of lymphoma. Eur J Nucl Med 1990;16: 755–771.
Front D, Israel O. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients. Semin Nucl Med 1995;25:60–71.
Front D, Ben-Haim S, Israel O, et al. Lymphoma: predictive value of Ga-67 scintigraphy after treatment. Radiology 1992;182:359–363.
Kostakoglu L, Yeh SD, Portlock C, et al. Validation of gallium-67 citrate single photon emission tomography in biopsy-confirmed residual Hodgkin’s disease in the mediastinum. J Nucl Med 1992;33:345–350.
Sanrock D, Iastoria S, Magrath IT, et al. The role of gallium-67 tumor scintigraphy in patients with small non-cleaved cell lymphoma. Eur J Nucl Med 1993;20:119–122.
Champion PE, Groshar D, Hooper IIR, et al. Does gallium uptake in the pulmonary hila predict involvement by non-Hodgkin’s lymphoma. Nucl Med Commun 1992;13:730–737.
Bar-Shalom R, Israel O, Haim N, et al. Diffuse lung uptake of Ga-67 after treatment of lymphoma: is it of clinical importance? Radiology 1996;199:473–476.
Abdel-Dayem HM, Scott AN, Macapinlac H, et al. Tracer imaging in lung cancer. Eur J Nucl Med 1994;21:57–81.
Kwekkeboom DJ, Kho GS, Lamberts SW, et al. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994;21: 1106–1113.
Sostre S, Villagra D, Morales ME, et al. Dualtracer scintigraphy and subtraction studies in the diagnosis of hepatocellular carcinoma. Cancer (Phila) 1988;61:670–672.
Beckerman C, Hoffer PB, Bitran JD. The role of gallium-67 in clinical evaluation of cancer. Semin Nucl Med 1984;14:296–322.
Front D, Bar-Shalom R, Israel O. The continuing clinical role of gallium-67 scintigraphy in the age of receptor imaging. Semin Nucl Med 1997;27: 68–74.
Kaplan WD, Jochelson MS, Herman TS, et al. Ga67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large cell lymphoma. J Clin Oncol 1990;8:1966–1970.
Carvalho PA, Schwartz RB, Alexander E, et al. Detection of recurrent gliomas with quantitative thallium-201/Tc-99m HMPAO SPECT. J Neurosurg 1992;77:565–570.
Dierckx TA, Martin JJ, Dobbeleir A, et al. Sensitivity and specificity of Tl-201 SPECT in the functional detection and differential diagnosis of brain tumors. Eur J Nucl Med 1994;21:621–633.
Kahn D, Follett KA, Bushnell DL, et al. Diagnosis of recurrent brain tumor: value of Tl-201 SPECT vs. F-18 FDG PET. AJR 1994;163: 1459–1465.
O’Malley JP, Ziessman HA, Kumar PN, et al. Diagnosis of intracranial lymphoma in patients with AIDS: value of Tl-201 SPECT. AJR 1994; 163:417–421.
Lorberboym M, Murthy S, Cechanick JI, et al. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma. J Nucl Med 1996;37:1487–1491.
Matsuno S, Tanabe M, Kawasaki Y, et al. Effectiveness of planar image and SPECT of Tl-201 compared with Ga-67 in patients with primary lung cancer. Eur J Nucl Med 1992; 19:86–95.
Waxman AD, Ramanna L, Memsic LD, et al. Tl-201 scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993; 34:18–23.
Ohtomo K, Terni S, Yodoyama R, et al. Tl-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med 1996;37:1444–1448.
Abdel-Dayem HM, Bag R, DiFabrizio L, et al. Evaluation of sequential thallium and gallium scans of the chest in AIDS patients. J Nucl Med 1996;37:1662–1667.
Rao VV, Chiu ML, Kronauge JF, Pwinica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of Tc-99m sestamibi. J Nucl Med 1994;35:510–515.
O’Tuama LA, Treves ST, Larar JN, et al. Tl-201 versus Tc-99m MIBI SPECT in evaluation of childhood brain tumors. J Nucl Med 1993; 34:1045–1051.
Khalkhali I, Cutrone JA, Mena IG, et al. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995; 196:421–426.
Waxman AD. The role of Tc-99m methoxyisobutylisonitrile in imaging breast cancer. Semin Nucl Med 1997;27:40–54.
Taki J, Sumiya H, Tsuchiya H, et al. Evaluating benign and malignant bone and soft tissue lesions with Tc-99m MIBI scintigraphy. J Nucl Med 1997;38:501–506.
Soderlund V, Johnson C, Bauer HCF, et al. Comparison of Tc-99m MIBI and Tc-99m tetrofosmin uptake by musculoskeletal sarcomas. J Nucl Med 1997;38:682–686.
Irvin GL, Prudhomme DL, Deriso GT, et al. A new approach to parathyroidectomy. Ann Surg 1994;219:579–581.
Aigner RM, Fueger GF, Nicoletti R. Parathyroid scintigraphy: comparison of Tc-99m MIBI and Tc-99m tetrofosmin studies. Eur J Nucl Med 1996;23:693–696
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kim, E.E., Wong, F.C.L. (2001). Targeted Single Photon Emission Computed Tomography in Oncology. In: Kim, E.E., Yang, D.J. (eds) Targeted Molecular Imaging in Oncology. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3505-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3505-5_10
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-3507-9
Online ISBN: 978-1-4757-3505-5
eBook Packages: Springer Book Archive